Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Research & Studies
Share your love
A novel multi-ingredient supplement significantly improves ocular symptom severity and tear production in patients with dry eye disease: results from a randomized, placebo-controlled clinical trial – Frontiers
A novel multi-ingredient supplement significantly improves ocular symptom severity and tear production in patients with dry eye disease: results from a randomized, placebo-controlled clinical trial Frontiers Source: Author: | Date: 2024-04-23 07:00:00 Source: Author: | Date: 2024-04-23 07:00:00
10 Organizations Making a Difference in Eye Health
In the vast and complex world of healthcare, eye health often doesn’t receive as much attention as it should, despite being crucial to our quality of life. Vision problems and blindness significantly affect millions of people globally, hindering education, employment,…
New Treatment Slows Down Progression of AMD, RP
A breakthrough study has unveiled a promising advancement in the treatment of incurable eye diseases such as age-related macular degeneration and retinitis pigmentosa. Researchers have successfully integrated anti-inflammatory drugs into a hydrogel, aiming to combat inflammation in the retina while…
iHealthScreen Wins US Patent for Glaucoma AI Tool
iHealthScreen has been granted a full US patent for its iPredict glaucoma detection model by the US Patent and Trademark Office (USPTO) as of March 26, 2024. This advanced model leverages AI and color fundus imaging to provide swift and…
Gemini and Bard Excel in Ophthalmology Board Exam
In a recent paper published in the journal Eye, Canadian researchers have evaluated the capabilities of two artificial intelligence chatbots, Google Gemini and Bard, in the ophthalmology board examination. They found that both AI tools achieved acceptable accuracy levels and…
Ocular Therapeutix Reports Promising Axpaxli Results in DR Study
Ocular Therapeutix announced positive topline results from its phase 1 HELIOS study, which evaluated the safety, tolerability, and efficacy of Axpaxli versus a sham control in patients with moderately severe to severe nonproliferative diabetic retinopathy (NPDR) without diabetic macular edema…
Blinking Enhances Visual Signal Strength, Study Finds
Researchers at the University of Rochester have discovered a new benefit of blinking—it enhances visual signal strength, in addition to its known role of keeping the eyes moist. This finding was revealed in a study led by Bin Yang, Janis…
Rare Cells Identified as Key to Color Perception
In a study published in the Journal of Neuroscience, researchers at the University of Rochester have made significant strides in understanding how humans perceive color. Utilizing adaptive optics, the team has identified rare retinal ganglion cells (RGCs) that could reshape…
Caplin Granted USFDA Approval for Key Ophthalmic Solution
Caplin Steriles Limited (Caplin), a subsidiary of Caplin Point Laboratories Limited, has received final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ketorolac Tromethamine Ophthalmic Solution 0.5%. This product is…
Pravin U. Dugel Becomes President & CEO at Ocular Therapeutix
Ocular Therapeutix announced a significant shift in its leadership structure, as Executive Chairman, Pravin U. Dugel, MD, will now also take on the roles of President and Chief Executive Officer. Dr. Dugel will continue his duties as a director and…